Healthcare PPP’s

For InterHealth Canada, a leading international healthcare group bidding for Diagnostic and Treatment Centers in the UK under the Public Private Partnership scheme which aimed to provide clinical and surgical services on a complete BOT project-financed basis. CR was lead advisor and chief negotiator and successfully led the transaction structuring and negotiation of commercial contracts and project financing for on two such deals (PPP Orthopedic Hospital at Runcorn and the PPP Orthopedic Facility at Kidderminster). CR closed the deals, securing the required debt and mezzanine financing for the project.

For InterHealth Canada, a hospital operator which is a leader in the integrated healthcare PPP model, provided strategic commercial and transactional advice on the Zywiec Integrated PPP Hospital project at the city of Zywiec in Poland.

For Mubadala Development International, a major sovereign fund, CR was lead advisor their investment in a joint venture with Imperial College, London to set up the Imperial College Diabetes Centre in Abu Dhabi.  CR was responsible for technical, commercial and financial analysis and due diligence on the deal as well as advising on partnership arrangements.

For a leading Korean healthcare operator, acting as sell-side advisor on a potential joint venture to export their expertise to the UAE and to structure services in a PPP model.

For KHIDI (Korea Health Industry Development Institute), a government organization established by the Korea Ministry of Health and Welfare that is responsible for promoting growth of the Korean healthcare industry, CR conducted research and completed a study entitled “Healthcare PPP Entry Strategy for Selected Markets”.  The purpose of this study was to provide meaningful data and analyses so that Korean health systems, engineering, procurement and construction contractors (EPCs), facility managers, and financial service institutions are able to assess the opportunities in various countries. It also provides them with insights into the attractions, key risks and benefits of participating in such opportunities in these markets. The mandate identified several opportunities which CR is now developing with KHIDI and potential Korean operators and investors.